Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 102 Issue 3, March 2022

The paper by Mohapatra et al. (p 298, this issue) describes how fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis. The cover shows images of developing zebrafish embryos as a model for this study.

Volume 102 Issue 3

Inside the USCAP Journals

Top of page ⤴

Article

Top of page ⤴

Supplement

Top of page ⤴

Search

Quick links